Prim Care Diabetes
February 2021
Aims: To evaluate the use of the electronic integral monitoring system (SMID) to identify factors associated to glycemic control and its impact in the quality of care in patients with type 2 diabetes (T2D).
Methods: T2D patients registered in SMID were analyzed. Biochemical, clinical and lifestyle variables were recorded.